drugset / Trial / NCT04224350
Study to Evaluate the Efficacy and Safety of Tacrolimus in Kidney Transplant Recipients (BLOSSOM)
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficacy and Safety after conversion to TacroBell SR cap. or TacroBell cap. in patients who in renal transplant patients undergoing maintenance therapy with Reference Tacrolimus.
Timeline
- Start
- 2018-12-17
- Primary completion
- 2020-07-30
- Completion
- 2020-11-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tacrolimus | Small molecule | 0.1 mg/kg | Oral |
| Subject | Tacrolimus | Small molecule | 0.2 mg/kg | Oral |
Indications
No indication recorded.